Neo-Green Herbs INC, the US subsidiary of Sichuan Neo-Green Pharmaceutical Technology Development Co., Ltd. (NGP), was founded in 2023. We carry the mantle of a parent company that has spent over two decades redefining the legacy of Traditional Chinese Medicine (TCM). NGP is not just a manufacturer; it is one of the six elite pilot manufacturers approved by the Chinese government to formulate and produce TCM granules, and the only such enterprise in Southwest China.
With a total asset value exceeding 30 billion RMB and a workforce of over 5,000 professionals, we are a powerhouse of innovation and reliability. Our mission is to empower global pharmacies and clinics through an efficient B2B supply chain, ensuring that the healing power of formulas like Magnolia Flower reaches those who need it with unprecedented purity and potency.
The global demand for Magnolia Flower Formula (Xin Yi Hua) has seen a significant surge in the past decade. As the world shifts toward "Clean Label" products and natural therapeutic alternatives, Magnolia—traditionally used for respiratory support and nasal health—has moved from ethnic apothecaries to mainstream health markets in North America, Europe, and Southeast Asia.
Industrial Status: Magnolia bark and flowers contain high concentrations of Magnolol and Honokiol, compounds now being researched for their neuroprotective, anti-inflammatory, and antioxidant properties. This has opened doors for Magnolia formulas in the nutraceutical, cosmetic, and pharmaceutical sectors globally. Leading manufacturers like Neo-Green Herbs are at the forefront of this industrial evolution, converting raw biomass into standardized granules and capsules that meet stringent Western pharmacopeia standards.
Development Trends: The industry is currently moving toward Full-Spectrum Standardization. B2B buyers no longer settle for simple powders; they require high-performance liquid chromatography (HPLC) fingerprints to ensure batch-to-batch consistency. Furthermore, the integration of AI and Big Data in TCM sourcing allows us to predict crop yields and active ingredient concentrations across our 300+ GAP (Good Agricultural Practice) bases, ensuring a stable supply chain despite climate fluctuations.
Procurement officers for medical institutions and herbal wholesalers prioritize three things: Traceability, Safety (Heavy Metals/Pesticides), and Potency. Neo-Green Herbs addresses these through our "Source-to-Shelf" model.
Localization Scenarios:
By offering both TCM granules and capsules, we provide localized delivery formats that match regional consumer habits—whether it's the traditional tea-making process or the modern on-the-go capsule convenience.
Professional workshops according to GAP, exclusive processes, and strict quality control standards ensure high purity and efficacy in every gram.
Every product comes from verified and certified channels, ensuring complete compliance and safety for clinics and patients worldwide.
Our parent company started Smart TCM Pharmacy research in 2002, leading the way in modernizing herb extraction and formula precision.
We provide comprehensive supply chain solutions, allowing clinics to purchase with confidence backed by international certifications.
Neo-Green Herbs empowers medical practitioners and pharmaceutical manufacturers with versatile applications.
At NGP, we have pioneered the "New Circular Economy of Traditional Chinese Medicine." This model integrates the entire industrial chain: from organic planting and breeding to TCM extraction and the ecological repurposing of dregs as fertilizer. This sustainable cycle ensures that our production of Magnolia Flower formulas respects the harmony between man and nature, fulfilling our corporate social responsibility while ensuring long-term resource availability.
Neo-Green Herbs
